Sartorius Stedim Biotech S.A. Stock Wiener Boerse
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 165.00 EUR | -5.28% |
|
-13.29% | -20.79% |
| 07-23 | Sartorius Stedim Biotech: Equipment inflects, margins beat - but guidance optics cloud the print |  |
| 07-23 | SARTORIUS STEDIM BIOTECH : Buy rating from RBC | ZD |
| Market Cap | 15.96B 18.16B 14.83B 13.63B 25.57B 1,753B 26.05B 177B 69.06B 859B 68.13B 66.66B 2,974B | P/E 2026 * |
41.7x | P/E 2027 * | 32.7x |
|---|---|---|---|---|---|
| Enterprise Value | 18.3B 20.82B 17B 15.63B 29.32B 2,011B 29.87B 203B 79.19B 985B 78.12B 76.43B 3,410B | EV / Sales 2026 * |
5.78x | EV / Sales 2027 * | 5.07x |
| Free-Float |
28.47% | Yield 2026 * |
0.52% | Yield 2027 * | 0.63% |
Last Transcript: Sartorius Stedim Biotech S.A.
| 1 day | -5.28% | ||
| 1 week | -13.29% | ||
| Current month | -8.38% | ||
| 1 month | +2.10% | ||
| 3 months | -10.67% | ||
| 6 months | -21.95% | ||
| Current year | -20.79% |
| 1 week | 160.3 |  | 188.8 |
| 1 month | 160.3 | | 190.3 |
| Current year | 152 | | 222.6 |
| 1 year | 152 | | 222.6 |
| 3 years | 144.4 | | 282.1 |
| 5 years | 144.4 | | 548.2 |
| 10 years | 144.4 | | 548.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.28% | -13.29% | - | - | 19.47B | |
| +0.18% | +12.86% | -19.87% | -11.85% | 175B | |
| +0.15% | +1.91% | -10.52% | -7.81% | 105B | |
| +1.49% | +2.86% | +4.13% | +58.40% | 58.48B | |
| -0.82% | -1.93% | +38.23% | +58.17% | 51.36B | |
| -0.12% | -1.23% | -15.62% | -42.24% | 42.2B | |
| +1.21% | -4.59% | - | - | 31.44B | |
| -1.33% | -3.09% | -17.20% | -46.03% | 27.56B | |
| -0.82% | -0.98% | +62.39% | -5.79% | 25.32B | |
| +0.03% | -0.39% | -5.83% | -9.24% | 20.52B | |
| Average | -0.53% | +0.60% | +4.46% | -0.80% | 59.65B | |
| Weighted average by Cap. | -0.06% | +3.97% | -4.06% | +0.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.17B 3.6B 2.94B 2.7B 5.07B 348B 5.17B 35.13B 13.7B 170B 13.51B 13.22B 590B | 3.5B 3.98B 3.25B 2.99B 5.6B 384B 5.71B 38.8B 15.13B 188B 14.92B 14.6B 651B |
| Net income | 380M 432M 353M 325M 609M 41.77B 621M 4.22B 1.65B 20.47B 1.62B 1.59B 70.84B | 475M 540M 441M 406M 761M 52.19B 775M 5.27B 2.06B 25.58B 2.03B 1.98B 88.52B |
| Net Debt | 2.34B 2.66B 2.17B 2B 3.75B 257B 3.82B 25.97B 10.13B 126B 9.99B 9.77B 436B | 1.77B 2.01B 1.64B 1.51B 2.83B 194B 2.89B 19.63B 7.65B 95.23B 7.55B 7.39B 330B |
| Date | Price | Change |
|---|---|---|
| 26-07-23 | €165.00 | -5.28% |
| 26-07-22 | €174.20 | +4.81% |
| 26-07-21 | €166.20 | -5.51% |
| 26-07-20 | €175.90 | -5.63% |
| 26-07-17 | €186.40 | -0.37% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
